WHO advises additional COVID shot for immunocompromised people
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Salesforce agrees to acquire AI research platform Listen Labs
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
Gavi’s Purchase of Additional Moderna’s (MRNA) mRNA-1273 Supply Supports Long-Term Outlook - Analyst
October 12, 2021 1:22 PM EDTEarlier today, Moderna, Inc. (Nasdaq: MRNA) today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility. Of these additional doses, 116.5 million doses are expected to be... More
COVAX Exercises Option to Purchase 176.5 Million Additional Doses of Moderna’s Moderna (MRNA) COVID-19 Vaccine
October 12, 2021 9:07 AM EDTModerna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Gavi, the Vaccine Alliance has exercised its option to purchase an additional 176.5 million doses of the Moderna COVID-19 vaccine for the COVAX Facility. Of these additional doses, 116.5 million doses... More
No New Safety Concerns Have Been Identified After An J&J (JNJ) Booster Shot - Johnson & Johnson In FDA Presentation - Reuters
October 12, 2021 9:06 AM EDTNo New Safety Concerns Have Been Identified After An Johnson & Johnson (NYSE: JNJ) Booster Shot - Johnson & Johnson In FDA Presentation - Reuters
... More